array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(661)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(66) "Bio-Rad’s Patent Threats Draw Suit to Clear Cancer-Research Test"
["snippet_en"]=>
string(240) "Bio-Rad Laboratories Inc. was hit with a lawsuit alleging its threats of patent-infringement litigation over ChromaCode Inc.'s high-definition genetic test used in cancer research is “a sword of Damocles over” the small biotech company."
["url"]=>
string(100) "https://news.bloomberglaw.com/ip-law/bio-rads-patent-threats-draw-suit-to-clear-cancer-research-test"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/db5d5e00-c873-474f-ada6-fa348923ef27"
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2023-09-21"
["categories"]=>
array(4) {
[0]=>
string(5) "R & D"
[1]=>
string(10) "Litigation"
[2]=>
string(5) "Legal"
[3]=>
string(27) "Business Model & Innovation"
}
}
[1]=>
array(7) {
["title_en"]=>
string(68) "10x Genomics Stock: The Illumina of Single-Cell Analysis? - Nanalyze"
["snippet_en"]=>
string(289) "The United States is famously the most litigious society in the world. One statistic we’ve come across is that the country spends about $310 billion a year on litigation. One particularly well-known American has been involved in some 3,500 lawsuits, perhaps skewing the statistics a bit."
["url"]=>
string(67) "https://www.nanalyze.com/2023/06/10x-genomics-single-cell-analysis/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/bfd907d9-d7f8-489a-aa19-b43d57ad5e65"
["source"]=>
string(12) "nanalyze.com"
["publication_date"]=>
string(10) "2023-06-19"
["categories"]=>
array(2) {
[0]=>
string(10) "Litigation"
[1]=>
string(5) "Legal"
}
}
[2]=>
array(7) {
["title_en"]=>
string(64) "Bio-Rad, Danaher’s Cytiva Settle Protein Purifying Patent Suit"
["snippet_en"]=>
string(222) "Danaher Corp.’s Cytiva Sweden AB and Bio-Rad Laboratories Inc. settled a patent-infringement lawsuit over a protein purification system used in biopharmaceutical research, according to a filing in Delaware federal court."
["url"]=>
string(97) "https://news.bloomberglaw.com/ip-law/bio-rad-danahers-cytiva-settle-protein-purifying-patent-suit"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c5acdc43-5f59-4f33-afd2-e64ca9d1753e"
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2022-07-01"
["categories"]=>
array(2) {
[0]=>
string(10) "Litigation"
[1]=>
string(5) "Legal"
}
}
[3]=>
array(7) {
["title_en"]=>
string(64) "Qiagen Sues Bio-Rad to Stave Off Patent Suit on DNA-Tagging Tech"
["snippet_en"]=>
string(254) "Qiagen NV filed a lawsuit Wednesday against Bio-Rad Laboratories Inc. seeking a federal court’ s judgment that Qiagen’ s QIAcuity system, which it says has been used in 48 states to test municipal wastewater for signs of Covid-19, doesn’ t infringe"
["url"]=>
string(101) "https://news.bloomberglaw.com/ip-law/qiagen-sues-bio-rad-to-stave-off-patent-suit-on-dna-tagging-tech"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/54380145-4298-49d2-9f3c-69c88b11fc5e"
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2022-04-06"
["categories"]=>
array(7) {
[0]=>
string(21) "Intellectual Property"
[1]=>
string(46) "Management of Legal and Regulatory Environment"
[2]=>
string(10) "Litigation"
[3]=>
string(8) "Epidemic"
[4]=>
string(27) "Business Model & Innovation"
[5]=>
string(8) "Verdicts"
[6]=>
string(5) "Legal"
}
}
[4]=>
array(7) {
["title_en"]=>
string(65) "Bio-Rad Trims Claims From Infringement Suit by Danaher’s Cytiva"
["snippet_en"]=>
string(252) "Bio-Rad Laboratories Inc.’s preparative protein purification system used in biopharmaceutical research doesn’t infringe six of a patent’s eight claims that Danaher Corp.’s Cytiva Sweden is asserting in a Delaware lawsuit, a federal judge ruled."
["url"]=>
string(99) "https://news.bloomberglaw.com/ip-law/bio-rad-trims-claims-from-infringement-suit-by-danahers-cytiva"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fc7f430d-e796-4fce-81d5-a7bc7ceb00a2"
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2022-03-15"
["categories"]=>
array(5) {
[0]=>
string(21) "Intellectual Property"
[1]=>
string(46) "Management of Legal and Regulatory Environment"
[2]=>
string(10) "Litigation"
[3]=>
string(8) "Verdicts"
[4]=>
string(5) "Legal"
}
}
[5]=>
array(7) {
["title_en"]=>
string(65) "Federal Circuit Denies Cibra Inc.'s Petition For Writ Of Mandamus"
["snippet_en"]=>
string(169) "The Federal Circuit rejected a bid by cloud infrastructure company Densify to revive a jury's patent infringement verdict against Morrison & Foerster client VMware, Inc."
["url"]=>
string(116) "https://www.mondaq.com/unitedstates/patent/1115742/federal-circuit-denies-cibra-inc39s-petition-for-writ-of-mandamus"
["image_url"]=>
string(105) "https://businessradar-prod-article-images.s3-eu-west-1.amazonaws.com/396ab275-9794-4db2-9261-2cdba934074e"
["source"]=>
string(10) "mondaq.com"
["publication_date"]=>
string(10) "2021-09-28"
["categories"]=>
array(4) {
[0]=>
string(20) "Business Development"
[1]=>
string(10) "Litigation"
[2]=>
string(5) "Legal"
[3]=>
string(8) "Verdicts"
}
}
[6]=>
array(7) {
["title_en"]=>
string(71) "Bio-Rad, Harvard settle DNA analysis patent dispute with French company"
["snippet_en"]=>
string(206) "Bio-Rad Laboratories has settled its patent infringement claims against French biotech company Stilla Technologies three days after the start of a trial in Boston federal court, according to a court filing."
["url"]=>
string(126) "https://www.reuters.com/legal/transactional/bio-rad-harvard-settle-dna-analysis-patent-dispute-with-french-company-2021-07-08/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3b60c69a-bc98-4e16-8fcd-86222fa59002"
["source"]=>
string(11) "reuters.com"
["publication_date"]=>
string(10) "2021-07-08"
["categories"]=>
array(9) {
[0]=>
string(16) "Case Settlements"
[1]=>
string(21) "Intellectual Property"
[2]=>
string(46) "Management of Legal and Regulatory Environment"
[3]=>
string(10) "Litigation"
[4]=>
string(17) "Business Disputes"
[5]=>
string(21) "Competitive Behaviour"
[6]=>
string(27) "Business Model & Innovation"
[7]=>
string(8) "Verdicts"
[8]=>
string(5) "Legal"
}
}
[7]=>
array(7) {
["title_en"]=>
string(38) "Case: Patents/Infringement (Fed. Cir.)"
["snippet_en"]=>
string(252) "The Federal Circuit affirmed the decisions of the International Trade Commission that 10X Genomics Inc. 's GEM Chips infringe Bio-Rad Laboratories Inc. 's gene-sequencing patents, but that 10X’ s Chip GB, which 10X uses internally but doesn’ t sell"
["url"]=>
string(73) "https://news.bloomberglaw.com/ip-law/case-patents-infringement-fed-cir-31"
["image_url"]=>
NULL
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2021-06-01"
["categories"]=>
array(2) {
[0]=>
string(10) "Litigation"
[1]=>
string(5) "Legal"
}
}
[8]=>
array(7) {
["title_en"]=>
string(36) "Case: Patents/Obviousness (P.T.A.B.)"
["snippet_en"]=>
string(249) "Claims of Bio-Rad Laboratories Inc. 's patent directed to a fluorescence detection system, having a movable excitation and detection module, for use with a thermal cycler, aren’ t unpatentable as obvious over prior art, the Patent Trial and Appeal"
["url"]=>
string(72) "https://news.bloomberglaw.com/ip-law/case-patents-obviousness-p-t-a-b-90"
["image_url"]=>
NULL
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2020-06-03"
["categories"]=>
array(2) {
[0]=>
string(10) "Litigation"
[1]=>
string(5) "Legal"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(31)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(28)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(13)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
661 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
Bio-Rad Laboratories Inc. was hit with a lawsuit alleging its threats of patent-infringement litigation over ChromaCode Inc.'s high-definition genetic test used in cancer research is “a sword of Damocles over” the small biotech company.
The United States is famously the most litigious society in the world. One statistic we’ve come across is that the country spends about $310 billion a year on litigation. One particularly well-known American has been involved in some 3,500 lawsuits, perhaps skewing the statistics a bit.
Danaher Corp.’s Cytiva Sweden AB and Bio-Rad Laboratories Inc. settled a patent-infringement lawsuit over a protein purification system used in biopharmaceutical research, according to a filing in Delaware federal court.
Qiagen NV filed a lawsuit Wednesday against Bio-Rad Laboratories Inc. seeking a federal court’ s judgment that Qiagen’ s QIAcuity system, which it says has been used in 48 states to test municipal wastewater for signs of Covid-19, doesn’ t infringe
Bio-Rad Laboratories Inc.’s preparative protein purification system used in biopharmaceutical research doesn’t infringe six of a patent’s eight claims that Danaher Corp.’s Cytiva Sweden is asserting in a Delaware lawsuit, a federal judge ruled.
The Federal Circuit rejected a bid by cloud infrastructure company Densify to revive a jury's patent infringement verdict against Morrison & Foerster client VMware, Inc.
Bio-Rad Laboratories has settled its patent infringement claims against French biotech company Stilla Technologies three days after the start of a trial in Boston federal court, according to a court filing.
The Federal Circuit affirmed the decisions of the International Trade Commission that 10X Genomics Inc. 's GEM Chips infringe Bio-Rad Laboratories Inc. 's gene-sequencing patents, but that 10X’ s Chip GB, which 10X uses internally but doesn’ t sell
Claims of Bio-Rad Laboratories Inc. 's patent directed to a fluorescence detection system, having a movable excitation and detection module, for use with a thermal cycler, aren’ t unpatentable as obvious over prior art, the Patent Trial and Appeal
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.